Drawing for TITAN

USPTO serial 88297055

TITAN

Reviewed by CopyMark Law Group

Reg. 5850143Status 702Registered
Filing date
Status date
Registration date
Sep 3, 2019
Examiner
VENGURLEKAR, SAGAR S
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with TITAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Chesal

Michael B. Chesal Peretz Chesal & Herrmann, P.L.1 S.E. 3rd Avenue, Suite 1820SunTrust International CenterMiami, FL 33131

Goods and services

ClassDescriptionStatusFirst use
045Regulatory and compliance consulting in the field of controlled and other regulated substances; Regulatory compliance consulting in the field of controlled and other regulated substances; Regulatory compliance consulting services in the field of the pharmaceutical industry for industry practices and government mandated policies, namely, auditing, investigative services, site surveys, and risk analysis; Reviewing standards and practices to assure compliance with the Controlled Substances Act (CSA) and other controlled substances laws and regulations of the United States and other governmental entities; Providing information regarding prescription drug theft, fraud, diversion or other crimes involving prescription drugs and other controlled substances; Providing a website featuring information about regulatory and compliance of controlled and other regulated substances; Providing a website featuring information about the pharmaceutical industry practices and government mandated policies, namely, auditing, investigative services, site surveys, and risk analysis; Providing a website featuring information about standards and practices to assure compliance with the Controlled Substances Act (CSA) and other controlled substances laws and regulations of the United States and other governmental entitiesACTIVEApr 12, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 22, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 22, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 2, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Sep 3, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 3, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 18, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 16, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 16, 2019ALIEASSIGNED TO LIE—
May 1, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 30, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 30, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 30, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 30, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 23, 2019DOCKASSIGNED TO EXAMINER—
Mar 5, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance